2022 Q4 Form 10-Q Financial Statement

#000121390022071537 Filed on November 14, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $2.534M $1.348M $1.422M
YoY Change -5.2%
Cost Of Revenue $1.463M $813.0K $896.0K
YoY Change -9.26%
Gross Profit $1.071M $535.0K $526.0K
YoY Change 1.71%
Gross Profit Margin 42.27% 39.69% 36.99%
Selling, General & Admin $2.358M $1.818M $882.0K
YoY Change 106.12%
% of Gross Profit 220.17% 339.81% 167.68%
Research & Development $717.0K $723.0K $552.0K
YoY Change 30.98%
% of Gross Profit 66.95% 135.14% 104.94%
Depreciation & Amortization -$6.000K $9.000K
YoY Change
% of Gross Profit -0.56% 1.68%
Operating Expenses $3.075M $2.541M $1.434M
YoY Change 77.2%
Operating Profit -$2.004M -$2.006M -$908.0K
YoY Change 120.93%
Interest Expense -$478.0K -$201.0K
YoY Change
% of Operating Profit
Other Income/Expense, Net -$201.0K -$279.0K
YoY Change -27.96%
Pretax Income -$2.482M -$2.207M
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$2.482M -$2.207M -$1.187M
YoY Change 85.93%
Net Earnings / Revenue -97.95% -163.72% -83.47%
Basic Earnings Per Share -$0.13 -$0.58
Diluted Earnings Per Share -$0.14 -$0.13 -$0.58
COMMON SHARES
Basic Shares Outstanding 17.32M shares 17.32M shares 2.049M shares
Diluted Shares Outstanding 17.32M shares 2.049M shares

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.565M $10.27M
YoY Change
Cash & Equivalents $3.943M $10.21M $966.0K
Short-Term Investments $1.622M $68.00K
Other Short-Term Assets $1.129M $1.299M
YoY Change
Inventory $1.179M $1.062M
Prepaid Expenses $473.0K
Receivables $3.034M $2.110M
Other Receivables $0.00 $0.00
Total Short-Term Assets $10.91M $14.75M
YoY Change 163.77%
LONG-TERM ASSETS
Property, Plant & Equipment $80.00K $108.0K
YoY Change -22.33%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $3.832M $1.472M
YoY Change
Total Long-Term Assets $3.912M $1.580M
YoY Change 612.57%
TOTAL ASSETS
Total Short-Term Assets $10.91M $14.75M
Total Long-Term Assets $3.912M $1.580M
Total Assets $14.82M $16.33M
YoY Change 216.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.781M $853.0K
YoY Change
Accrued Expenses $1.190M $2.134M
YoY Change 46.37%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $553.0K $777.0K
YoY Change -27.04%
Total Short-Term Liabilities $6.202M $5.591M
YoY Change 4.22%
LONG-TERM LIABILITIES
Long-Term Debt $4.625M $4.374M
YoY Change
Other Long-Term Liabilities $727.0K $52.00K
YoY Change 820.25%
Total Long-Term Liabilities $5.352M $5.171M
YoY Change -58.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.202M $5.591M
Total Long-Term Liabilities $5.352M $5.171M
Total Liabilities $11.55M $10.76M
YoY Change -38.2%
SHAREHOLDERS EQUITY
Retained Earnings -$33.40M -$30.92M
YoY Change 48.98%
Common Stock $1.000K $1.000K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.265M $5.563M -$16.27M
YoY Change
Total Liabilities & Shareholders Equity $14.82M $16.33M
YoY Change 216.37%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$2.482M -$2.207M -$1.187M
YoY Change 85.93%
Depreciation, Depletion And Amortization -$6.000K $9.000K
YoY Change
Cash From Operating Activities -$1.992M -$1.994M
YoY Change
INVESTING ACTIVITIES
Capital Expenditures -$34.00K -$18.00K
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$3.966M $3.000K
YoY Change
Cash From Investing Activities -$3.932M -$15.00K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -742.0K -193.0K
YoY Change
NET CHANGE
Cash From Operating Activities -1.992M -1.994M
Cash From Investing Activities -3.932M -15.00K
Cash From Financing Activities -742.0K -193.0K
Net Change In Cash -6.666M -2.202M
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$1.992M -$1.994M
Capital Expenditures -$34.00K -$18.00K
Free Cash Flow -$1.958M -$1.976M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
usd
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-41375
dei Entity Registrant Name
EntityRegistrantName
ACTELIS NETWORKS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
52-2160309
dei Entity Address Address Line1
EntityAddressAddressLine1
4039 Clipper Court
dei Entity Address City Or Town
EntityAddressCityOrTown
Fremont
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94538
dei City Area Code
CityAreaCode
(510)
dei Local Phone Number
LocalPhoneNumber
545-1045
dei Security12b Title
Security12bTitle
Common Stock, $0.0001 par value per share
dei Trading Symbol
TradingSymbol
ASNS
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
17317572 shares
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10206000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
693000 usd
CY2022Q3 us-gaap Short Term Investments
ShortTermInvestments
68000 usd
CY2022Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
650000 usd
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
124000 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
61000 usd
CY2022Q3 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
2110000 usd
CY2021Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
2147000 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
1062000 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
897000 usd
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
649000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
398000 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
14745000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
4135000 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
108000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
103000 usd
CY2022Q3 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
245000 usd
CY2022Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
89000 usd
CY2021Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
102000 usd
CY2022Q3 us-gaap Restricted Investments Noncurrent
RestrictedInvestmentsNoncurrent
239000 usd
CY2021Q4 us-gaap Restricted Investments Noncurrent
RestrictedInvestmentsNoncurrent
266000 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
818000 usd
CY2022Q3 us-gaap Long Term Investments
LongTermInvestments
81000 usd
CY2021Q4 us-gaap Long Term Investments
LongTermInvestments
78000 usd
CY2022Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
1580000 usd
CY2021Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
549000 usd
CY2022Q3 us-gaap Assets
Assets
16325000 usd
CY2021Q4 us-gaap Assets
Assets
4684000 usd
CY2022Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
777000 usd
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
758000 usd
CY2022Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
27000 usd
CY2021Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
177000 usd
CY2022Q3 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
853000 usd
CY2021Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
1920000 usd
CY2022Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
625000 usd
CY2021Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
673000 usd
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
695000 usd
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
703000 usd
CY2022Q3 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
1006000 usd
CY2021Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
818000 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
480000 usd
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1128000 usd
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
902000 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
5591000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5951000 usd
CY2022Q3 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
4374000 usd
CY2021Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
5473000 usd
CY2022Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
193000 usd
CY2021Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
1972000 usd
CY2021Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
4905000 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
276000 usd
CY2022Q3 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
276000 usd
CY2021Q4 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
315000 usd
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
52000 usd
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
79000 usd
CY2022Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
5171000 usd
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
12744000 usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-41375
dei Entity Registrant Name
EntityRegistrantName
ACTELIS NETWORKS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
52-2160309
dei Entity Address Address Line1
EntityAddressAddressLine1
4039 Clipper Court
dei Entity Address City Or Town
EntityAddressCityOrTown
Fremont
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94538
dei City Area Code
CityAreaCode
(510)
dei Local Phone Number
LocalPhoneNumber
545-1045
dei Security12b Title
Security12bTitle
Common Stock, $0.0001 par value per share
dei Trading Symbol
TradingSymbol
ASNS
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
17317572 shares
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10206000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
693000 usd
CY2022Q3 us-gaap Short Term Investments
ShortTermInvestments
68000 usd
CY2022Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
650000 usd
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
124000 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
61000 usd
CY2022Q3 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
2110000 usd
CY2021Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
2147000 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
1062000 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
897000 usd
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
649000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
398000 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
14745000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
4135000 usd
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q3 us-gaap Liabilities
Liabilities
10762000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
18695000 usd
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
7988691 shares
CY2021Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
5585000 usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
11009315 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17317572 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17317572 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2047641 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2047641 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
1000 usd
CY2022Q3 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
2803774 shares
CY2021Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
2803774 shares
CY2022Q3 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
0 shares
CY2022Q3 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2021Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
1783773 shares
CY2021Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
1783773 shares
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
36482000 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2824000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-30920000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-22420000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
5563000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-19596000 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
16325000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4684000 usd
CY2022Q3 us-gaap Revenues
Revenues
1348000 usd
CY2021Q3 us-gaap Revenues
Revenues
1422000 usd
us-gaap Revenues
Revenues
6297000 usd
us-gaap Revenues
Revenues
5995000 usd
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
813000 usd
CY2021Q3 us-gaap Cost Of Revenue
CostOfRevenue
896000 usd
us-gaap Cost Of Revenue
CostOfRevenue
3258000 usd
us-gaap Cost Of Revenue
CostOfRevenue
3002000 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
535000 usd
CY2021Q3 us-gaap Gross Profit
GrossProfit
526000 usd
us-gaap Gross Profit
GrossProfit
3039000 usd
us-gaap Gross Profit
GrossProfit
2993000 usd
CY2022Q3 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
723000 usd
CY2021Q3 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
552000 usd
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
2049000 usd
CY2021Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
627000 usd
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
1818000 usd
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
790000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2357000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1576000 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1028000 usd
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
255000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2730000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
906000 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
2541000 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
1434000 usd
us-gaap Operating Expenses
OperatingExpenses
7136000 usd
us-gaap Operating Expenses
OperatingExpenses
4300000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2006000 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-908000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-4097000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1307000 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-201000 usd
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-279000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4403000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-592000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-2207000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-1187000 usd
us-gaap Net Income Loss
NetIncomeLoss
-8500000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1899000 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.58
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.88
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.93
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17317532 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2049433 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9687205 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2048241 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-14398000 usd
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
10000 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-679000 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-15067000 usd
CY2021Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
8000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-33000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-15092000 usd
CY2021Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
10000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-1187000 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-16269000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-19596000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
14000 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
108000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
103000 usd
CY2022Q3 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
245000 usd
CY2022Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
89000 usd
CY2021Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
102000 usd
CY2022Q3 us-gaap Restricted Investments Noncurrent
RestrictedInvestmentsNoncurrent
239000 usd
CY2021Q4 us-gaap Restricted Investments Noncurrent
RestrictedInvestmentsNoncurrent
266000 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
818000 usd
CY2022Q3 us-gaap Long Term Investments
LongTermInvestments
81000 usd
CY2021Q4 us-gaap Long Term Investments
LongTermInvestments
78000 usd
CY2022Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
1580000 usd
CY2021Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
549000 usd
CY2022Q3 us-gaap Assets
Assets
16325000 usd
CY2021Q4 us-gaap Assets
Assets
4684000 usd
CY2022Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
777000 usd
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
758000 usd
CY2022Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
27000 usd
CY2021Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
177000 usd
CY2022Q3 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
853000 usd
CY2021Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
1920000 usd
CY2022Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
625000 usd
CY2021Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
673000 usd
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
695000 usd
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
703000 usd
CY2022Q3 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
1006000 usd
CY2021Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
818000 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
480000 usd
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1128000 usd
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
902000 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
5591000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5951000 usd
CY2022Q3 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
4374000 usd
CY2021Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
5473000 usd
CY2022Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
193000 usd
CY2021Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
1972000 usd
CY2021Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
4905000 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
276000 usd
CY2022Q3 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
276000 usd
CY2021Q4 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
315000 usd
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
52000 usd
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
79000 usd
CY2022Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
5171000 usd
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
12744000 usd
CY2022Q3 us-gaap Liabilities
Liabilities
10762000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
18695000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-4639000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-24221000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
14000 usd
CY2022Q2 asns Stock Issued During Period Value Conversion Of Convertible Preferred Stock To Common Stock Upon Initial Public Offering
StockIssuedDuringPeriodValueConversionOfConvertiblePreferredStockToCommonStockUponInitialPublicOffering
5585000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
14675000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
6553000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
3600000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
3190000 usd
CY2022Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
15000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1654000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
7757000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
13000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-2207000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
5563000 usd
us-gaap Net Income Loss
NetIncomeLoss
-8500000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1899000 usd
us-gaap Depreciation
Depreciation
29000 usd
us-gaap Depreciation
Depreciation
29000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1068000 usd
us-gaap Inventory Write Down
InventoryWriteDown
106000 usd
us-gaap Inventory Write Down
InventoryWriteDown
55000 usd
asns Exchange Rate Differences
ExchangeRateDifferences
-798000 usd
asns Exchange Rate Differences
ExchangeRateDifferences
15000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
41000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
28000 usd
asns Changes In Fair Value Related To Convertible Loan
ChangesInFairValueRelatedToConvertibleLoan
1648000 usd
asns Changes In Fair Value Related To Convertible Note
ChangesInFairValueRelatedToConvertibleNote
1753000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-37000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
30000 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
62000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
271000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
30000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
251000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
6000 usd
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
245000 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-1067000 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-845000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
145000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
713000 usd
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
180000 usd
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
258000 usd
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
185000 usd
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
179000 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
226000 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
55000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5776000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1478000 usd
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
-68000 usd
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
7988691 shares
CY2021Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
5585000 usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
11009315 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17317572 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17317572 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2047641 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2047641 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
1000 usd
CY2022Q3 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
2803774 shares
CY2021Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
2803774 shares
CY2022Q3 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
0 shares
CY2022Q3 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2021Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
1783773 shares
CY2021Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
1783773 shares
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
36482000 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2824000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-30920000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-22420000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
5563000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-19596000 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
16325000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4684000 usd
CY2022Q3 us-gaap Revenues
Revenues
1348000 usd
CY2021Q3 us-gaap Revenues
Revenues
1422000 usd
us-gaap Revenues
Revenues
6297000 usd
us-gaap Revenues
Revenues
5995000 usd
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
813000 usd
CY2021Q3 us-gaap Cost Of Revenue
CostOfRevenue
896000 usd
us-gaap Cost Of Revenue
CostOfRevenue
3258000 usd
us-gaap Cost Of Revenue
CostOfRevenue
3002000 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
535000 usd
CY2021Q3 us-gaap Gross Profit
GrossProfit
526000 usd
us-gaap Gross Profit
GrossProfit
3039000 usd
us-gaap Gross Profit
GrossProfit
2993000 usd
CY2022Q3 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
723000 usd
CY2021Q3 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
552000 usd
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
2049000 usd
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
1818000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
34000 usd
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
790000 usd
CY2021Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
627000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2357000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1576000 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1028000 usd
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
255000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2730000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
906000 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
2541000 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
1434000 usd
us-gaap Operating Expenses
OperatingExpenses
7136000 usd
us-gaap Operating Expenses
OperatingExpenses
4300000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2006000 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-908000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-4097000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1307000 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-201000 usd
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-279000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4403000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-592000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-2207000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-1187000 usd
us-gaap Net Income Loss
NetIncomeLoss
-8500000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1899000 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.58
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.88
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.93
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17317532 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2049433 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9687205 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2048241 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-14398000 usd
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
10000 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-679000 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-15067000 usd
CY2021Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
8000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-33000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-15092000 usd
CY2021Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
10000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-1187000 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-16269000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-19596000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
14000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-4639000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-102000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6000 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
2070000 usd
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
18712000 usd
us-gaap Payments For Repurchase Of Initial Public Offering
PaymentsForRepurchaseOfInitialPublicOffering
2175000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
509000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
192000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
16028000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1878000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
46000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-2000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
10150000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
394000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
795000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
671000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10945000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1065000 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10206000 usd
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
966000 usd
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
650000 usd
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
89000 usd
CY2021Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
99000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
10945000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1065000 usd
us-gaap Interest Paid Net
InterestPaidNet
527000 usd
us-gaap Interest Paid Net
InterestPaidNet
406000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
184000 usd
CY2022Q2 asns Underwriter Option To Purchase
UnderwriterOptionToPurchase
462500 shares
CY2022Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
4
us-gaap Underwriting Income Loss
UnderwritingIncomeLoss
1400000 usd
CY2021Q4 us-gaap Shares Issued
SharesIssued
900096 shares
CY2022Q2 us-gaap Shares Issued
SharesIssued
900096 shares
CY2022Q3 us-gaap Shares Issued
SharesIssued
180000 shares
us-gaap Sale Of Stock Description Of Transaction
SaleOfStockDescriptionOfTransaction
The warrants are exercisable into 294,875 of the Company’s common shares for an exercise price of $5 per share and can be exercised at any time during a period of 5 years from the issuance date (i.e. until May 17, 2027). The Warrants are classified as equity based on the guidance provided under ASC 718-10.As of the issuance date, the fair value of the warrants was estimated at $145. The valuation was based on a Black-Scholes option-pricing model, using an expected volatility of 54%, a risk-free rate of 3.01%, an expected term of 5 years, an expected dividend yield of 0% and a stock price at the issuance date of $1.95. 
asns Warrants Exercisable
WarrantsExercisable
294875 shares
CY2022Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
5
us-gaap Common Stock Voting Rights
CommonStockVotingRights
The Company redeemed 1,783,773 shares of non-voting common stock at their par value, removing the stock from shareholders’ equity.
CY2022Q2 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
14675000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
6553000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
3600000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
3190000 usd
CY2022Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
15000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-24221000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
14000 usd
CY2022Q2 asns Stock Issued During Period Value Conversion Of Convertible Preferred Stock To Common Stock Upon Initial Public Offering
StockIssuedDuringPeriodValueConversionOfConvertiblePreferredStockToCommonStockUponInitialPublicOffering
5585000 usd
us-gaap Use Of Estimates
UseOfEstimates
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.75in"/><td style="width: 0.25in; text-align: left">b)</td><td style="text-align: justify"><b>Use of estimates in preparation of financial statements</b></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.65pt; text-align: justify; text-indent: 0in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The preparation of the unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. The Company evaluates on an ongoing basis its assumptions, including those related to contingencies, Fair values of financial instruments, inventory write-offs, as well as in estimates used in applying the revenue recognition policy. The Company’s management believes that the estimates, judgments, and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the unaudited condensed consolidated financial statements, and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.95in; text-align: justify; text-indent: 0in"> </p>
CY2021Q3 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
162000 usd
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
473000 usd
CY2022Q3 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
168000 usd
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
504000 usd
CY2022Q3 asns Right Of Use Asset
RightOfUseAsset
1046000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1654000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
7757000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
13000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-2207000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
5563000 usd
us-gaap Net Income Loss
NetIncomeLoss
-8500000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1899000 usd
us-gaap Depreciation
Depreciation
29000 usd
us-gaap Depreciation
Depreciation
29000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1068000 usd
us-gaap Inventory Write Down
InventoryWriteDown
106000 usd
us-gaap Inventory Write Down
InventoryWriteDown
55000 usd
asns Exchange Rate Differences
ExchangeRateDifferences
-798000 usd
asns Exchange Rate Differences
ExchangeRateDifferences
15000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
41000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
28000 usd
asns Changes In Fair Value Related To Convertible Loan
ChangesInFairValueRelatedToConvertibleLoan
1648000 usd
asns Changes In Fair Value Related To Convertible Note
ChangesInFairValueRelatedToConvertibleNote
1753000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-37000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
30000 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
62000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
271000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
30000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
251000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
6000 usd
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
245000 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-1067000 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-845000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
145000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
713000 usd
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
180000 usd
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
258000 usd
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
185000 usd
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
179000 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
226000 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
55000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5776000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1478000 usd
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
-68000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
34000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-102000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6000 usd
CY2022Q3 us-gaap Deferred Offering Costs
DeferredOfferingCosts
1450000 usd
us-gaap Product Warranty Expense
ProductWarrantyExpense
27000 usd
CY2021Q4 us-gaap Other Notes Payable
OtherNotesPayable
4905000 usd
CY2021 us-gaap Product Warranty Expense
ProductWarrantyExpense
2149000 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.75in"/><td style="width: 0.25in; text-align: left">i)</td><td style="text-align: justify"><b>Concentration of risk</b></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">The Company has major customers, representing:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="width: 92.7pt"/><td style="width: 18pt">1.</td><td style="text-align: justify">36% and 47% of the Company Trade receivables balance as of September 30, 2022 and December 31, 2021 respectively.</td></tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="width: 92.7pt"/><td style="width: 18pt">2.</td><td style="text-align: justify">29% and 0% of the Company Trade receivables balance as of September 30, 2022 and December 31, 2021 respectively.</td></tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="width: 92.7pt"/><td style="width: 18pt">3.</td><td style="text-align: justify">6% and 21% of the Company Trade receivables balance as of September 30, 2022 and December 31, 2021 respectively.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">The Company does not see any credit risk regarding this debt, as most of the remaining balance was paid off after the balance sheet date.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">See note 11 for details regarding the revenues from these customers.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"> </p>
CY2022Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
585000 usd
CY2021Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
356000 usd
CY2022Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
477000 usd
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
541000 usd
CY2022Q3 us-gaap Inventory Gross
InventoryGross
1062000 usd
CY2021Q4 us-gaap Inventory Gross
InventoryGross
897000 usd
CY2022Q3 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
106000 usd
CY2021Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
55000 usd
asns Convertible Note Offering Amount
ConvertibleNoteOfferingAmount
3000000 usd
asns Convertible Note Offering Percentage
ConvertibleNoteOfferingPercentage
0.06 pure
CY2022Q2 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.06 pure
CY2022Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
60000 usd
asns Convertible Note Description
ConvertibleNoteDescription
The Notes had an optional conversion price at a 40% discount based on a $50m value in the event that an IPO is not consummated and if an IPO is not consummated within 18 months of the issuance of the Notes, the value of the Notes would be set at 110% of their then balance. 
CY2022Q2 us-gaap Public Utilities Requested Rate Increase Decrease Percentage
PublicUtilitiesRequestedRateIncreaseDecreasePercentage
0.25 pure
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.58 pure
CY2022Q2 asns Risk Free Rate Percentage
RiskFreeRatePercentage
0.0241 pure
asns Addition
Addition
1847000 usd
us-gaap Other Comprehensive Income Other Net Of Tax
OtherComprehensiveIncomeOtherNetOfTax
1753000 usd
us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
3600000 usd
CY2022Q3 us-gaap Other Expenses
OtherExpenses
0 usd
us-gaap Other Expenses
OtherExpenses
1753000 usd
CY2017Q1 asns Aggregrate Principal Amount
AggregratePrincipalAmount
2000000 usd
asns Ipo Scenario Estimated Percentage
IPOScenarioEstimatedPercentage
0.75 pure
CY2021 asns Ipo Scenario Estimated Percentage
IPOScenarioEstimatedPercentage
0.375 pure
CY2022Q1 us-gaap Additional Liability Long Duration Insurance Current Weighted Average Discount Rate
AdditionalLiabilityLongDurationInsuranceCurrentWeightedAverageDiscountRate
0.40 pure
CY2022Q1 us-gaap Debt Conversion Converted Instrument Rate
DebtConversionConvertedInstrumentRate
0.772 pure
CY2021 us-gaap Debt Conversion Converted Instrument Rate
DebtConversionConvertedInstrumentRate
0.772 pure
CY2022Q1 us-gaap Financial Guarantee Insurance Contracts Claim Liability Weighted Average Risk Free Discount Rate
FinancialGuaranteeInsuranceContractsClaimLiabilityWeightedAverageRiskFreeDiscountRate
0.214 pure
CY2021 us-gaap Financial Guarantee Insurance Contracts Claim Liability Weighted Average Risk Free Discount Rate
FinancialGuaranteeInsuranceContractsClaimLiabilityWeightedAverageRiskFreeDiscountRate
0.208 pure
CY2022Q1 asns Share Based Goods And Nonemployee Services Transaction Valuations Method Expected Dividend Rate
ShareBasedGoodsAndNonemployeeServicesTransactionValuationsMethodExpectedDividendRate
0.25 pure
CY2021 asns Share Based Goods And Nonemployee Services Transaction Valuations Method Expected Dividend Rate
ShareBasedGoodsAndNonemployeeServicesTransactionValuationsMethodExpectedDividendRate
0.625 pure
CY2022Q1 asns Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm
P2Y9M
CY2021 asns Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm
P3Y
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
2070000 usd
CY2022Q1 us-gaap Equity Fair Value Adjustment
EquityFairValueAdjustment
26500000 usd
CY2021 us-gaap Equity Fair Value Adjustment
EquityFairValueAdjustment
24300000 usd
CY2022Q1 asns Volatility Percentages
VolatilityPercentages
0.58 pure
CY2021 asns Volatility Percentages
VolatilityPercentages
0.58 pure
CY2022Q1 asns Riskfree Rate Percentage
RiskfreeRatePercentage
0.0241 pure
CY2021 asns Riskfree Rate Percentage
RiskfreeRatePercentage
0.0097 pure
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
18712000 usd
us-gaap Payments For Repurchase Of Initial Public Offering
PaymentsForRepurchaseOfInitialPublicOffering
2175000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
509000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
192000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
16028000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1878000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
46000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-2000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
10150000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
394000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
795000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
671000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10945000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1065000 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10206000 usd
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
966000 usd
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
650000 usd
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
89000 usd
CY2021Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
99000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
10945000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1065000 usd
us-gaap Interest Paid Net
InterestPaidNet
527000 usd
us-gaap Interest Paid Net
InterestPaidNet
406000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
184000 usd
CY2022Q2 asns Underwriter Option To Purchase
UnderwriterOptionToPurchase
462500 shares
CY2022Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
4
us-gaap Underwriting Income Loss
UnderwritingIncomeLoss
1400000 usd
CY2021Q4 us-gaap Shares Issued
SharesIssued
900096 shares
CY2022Q2 us-gaap Shares Issued
SharesIssued
900096 shares
CY2022Q3 us-gaap Shares Issued
SharesIssued
180000 shares
us-gaap Sale Of Stock Description Of Transaction
SaleOfStockDescriptionOfTransaction
The warrants are exercisable into 294,875 of the Company’s common shares for an exercise price of $5 per share and can be exercised at any time during a period of 5 years from the issuance date (i.e. until May 17, 2027). The Warrants are classified as equity based on the guidance provided under ASC 718-10.As of the issuance date, the fair value of the warrants was estimated at $145. The valuation was based on a Black-Scholes option-pricing model, using an expected volatility of 54%, a risk-free rate of 3.01%, an expected term of 5 years, an expected dividend yield of 0% and a stock price at the issuance date of $1.95. 
asns Warrants Exercisable
WarrantsExercisable
294875 shares
CY2022Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
5
us-gaap Common Stock Voting Rights
CommonStockVotingRights
The Company redeemed 1,783,773 shares of non-voting common stock at their par value, removing the stock from shareholders’ equity.
CY2022Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
4905000 usd
CY2021Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
3563000 usd
us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
1648000 usd
CY2021 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
1342000 usd
asns Conversion Of Stock Amount Issued
ConversionOfStockAmountIssued
6553000 usd
CY2021 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
4905000 usd
CY2022Q3 us-gaap Costs And Expenses
CostsAndExpenses
0 usd
CY2021Q3 us-gaap Costs And Expenses
CostsAndExpenses
1648000 usd
us-gaap Costs And Expenses
CostsAndExpenses
0 usd
us-gaap Costs And Expenses
CostsAndExpenses
0 usd
CY2016Q3 us-gaap Stock Issued During Period Shares Purchase Of Assets
StockIssuedDuringPeriodSharesPurchaseOfAssets
73048 shares
CY2021 asns Ipo Scenario Estimated Percentage
IPOScenarioEstimatedPercentage
0.375 pure
CY2021 asns Private Holding Percenatge
PrivateHoldingPercenatge
0.625 pure
CY2021 asns Volatility Percentage
VolatilityPercentage
0.58 pure
CY2021 asns Riskfree Rate Percentage
RiskfreeRatePercentage
0.0097 pure
CY2021 us-gaap Debt Instrument Term
DebtInstrumentTerm
P0Y4M24D
CY2021 asns Ipo Scenario Expected Term
IPOScenarioExpectedTerm
P3Y
CY2022Q3 asns Underlying Common Stock Price
UnderlyingCommonStockPrice
0.875
asns Volatility Percentage
VolatilityPercentage
0.57 pure
asns Risk Free Rate Percentage
RiskFreeRatePercentage
0.0416 pure
us-gaap Debt Instrument Term
DebtInstrumentTerm
P3Y10M24D
CY2021Q4 us-gaap Servicing Asset At Fair Value Amount
ServicingAssetAtFairValueAmount
2149000 usd
CY2020Q4 us-gaap Servicing Asset At Fair Value Amount
ServicingAssetAtFairValueAmount
1023000 usd
us-gaap Servicing Liability At Fair Value Other Changes In Fair Value
ServicingLiabilityAtFairValueOtherChangesInFairValue
1068000 usd
CY2021 us-gaap Servicing Liability At Fair Value Other Changes In Fair Value
ServicingLiabilityAtFairValueOtherChangesInFairValue
1031000 usd
CY2021 us-gaap Servicing Asset At Fair Value Additions
ServicingAssetAtFairValueAdditions
95000 usd
CY2022Q3 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
3190000 usd
CY2022Q3 us-gaap Servicing Asset At Fair Value Amount
ServicingAssetAtFairValueAmount
27000 usd
CY2021Q4 us-gaap Servicing Asset At Fair Value Amount
ServicingAssetAtFairValueAmount
2149000 usd
CY2022Q3 us-gaap Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
-47000 usd
us-gaap Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
1068000 usd
CY2021Q3 us-gaap Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
0 usd
us-gaap Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
0 usd
us-gaap Lease Income
LeaseIncome
121000 usd
us-gaap Use Of Estimates
UseOfEstimates
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.75in"/><td style="width: 0.25in; text-align: left">b)</td><td style="text-align: justify"><b>Use of estimates in preparation of financial statements</b></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.65pt; text-align: justify; text-indent: 0in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The preparation of the unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. The Company evaluates on an ongoing basis its assumptions, including those related to contingencies, Fair values of financial instruments, inventory write-offs, as well as in estimates used in applying the revenue recognition policy. The Company’s management believes that the estimates, judgments, and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the unaudited condensed consolidated financial statements, and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.95in; text-align: justify; text-indent: 0in"> </p>
CY2021Q3 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
162000 usd
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
473000 usd
CY2022Q3 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
168000 usd
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
504000 usd
CY2022Q3 asns Right Of Use Asset
RightOfUseAsset
1046000 usd
CY2022Q3 us-gaap Deferred Offering Costs
DeferredOfferingCosts
1450000 usd
CY2022Q3 us-gaap Lease Income
LeaseIncome
40000 usd
us-gaap Product Warranty Expense
ProductWarrantyExpense
27000 usd
CY2021Q4 us-gaap Other Notes Payable
OtherNotesPayable
4905000 usd
CY2021 us-gaap Product Warranty Expense
ProductWarrantyExpense
2149000 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.75in"/><td style="width: 0.25in; text-align: left">i)</td><td style="text-align: justify"><b>Concentration of risk</b></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">The Company has major customers, representing:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="width: 92.7pt"/><td style="width: 18pt">1.</td><td style="text-align: justify">36% and 47% of the Company Trade receivables balance as of September 30, 2022 and December 31, 2021 respectively.</td></tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="width: 92.7pt"/><td style="width: 18pt">2.</td><td style="text-align: justify">29% and 0% of the Company Trade receivables balance as of September 30, 2022 and December 31, 2021 respectively.</td></tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="width: 92.7pt"/><td style="width: 18pt">3.</td><td style="text-align: justify">6% and 21% of the Company Trade receivables balance as of September 30, 2022 and December 31, 2021 respectively.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">The Company does not see any credit risk regarding this debt, as most of the remaining balance was paid off after the balance sheet date.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">See note 11 for details regarding the revenues from these customers.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"> </p>
CY2022Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
585000 usd
CY2021Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
356000 usd
CY2022Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
477000 usd
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
541000 usd
CY2022Q3 us-gaap Inventory Gross
InventoryGross
1062000 usd
CY2021Q4 us-gaap Inventory Gross
InventoryGross
897000 usd
CY2022Q3 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
106000 usd
CY2021Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
55000 usd
CY2022Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
60000 usd
asns Convertible Note Description
ConvertibleNoteDescription
The Notes had an optional conversion price at a 40% discount based on a $50m value in the event that an IPO is not consummated and if an IPO is not consummated within 18 months of the issuance of the Notes, the value of the Notes would be set at 110% of their then balance. 
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
818000 usd
CY2022Q3 asns Current Operating Lease Liabilities
CurrentOperatingLeaseLiabilities
480000 usd
CY2022Q3 asns Non Current Operating Lease Liabilities
NonCurrentOperatingLeaseLiabilities
276000 usd
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
756000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
520000 usd
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y6M18D
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0311 pure
us-gaap Operating Lease Cost
OperatingLeaseCost
504000 usd
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
168000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
16000 usd
CY2022Q3 us-gaap Variable Lease Cost
VariableLeaseCost
8000 usd
us-gaap Lease Cost
LeaseCost
520000 usd
CY2022Q3 us-gaap Lease Cost
LeaseCost
178000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
150000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
444000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
153000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
61000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
808000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
52000 usd
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
756000 usd
asns Convertible Note Offering Amount
ConvertibleNoteOfferingAmount
3000000 usd
asns Convertible Note Offering Percentage
ConvertibleNoteOfferingPercentage
0.06 pure
CY2022Q2 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.06 pure
CY2022Q2 us-gaap Public Utilities Requested Rate Increase Decrease Percentage
PublicUtilitiesRequestedRateIncreaseDecreasePercentage
0.25 pure
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.58 pure
CY2022Q2 asns Risk Free Rate Percentage
RiskFreeRatePercentage
0.0241 pure
asns Addition
Addition
1847000 usd
us-gaap Other Comprehensive Income Other Net Of Tax
OtherComprehensiveIncomeOtherNetOfTax
1753000 usd
us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
3600000 usd
CY2022Q3 us-gaap Other Expenses
OtherExpenses
0 usd
us-gaap Other Expenses
OtherExpenses
1753000 usd
CY2017Q1 asns Aggregrate Principal Amount
AggregratePrincipalAmount
2000000 usd
asns Ipo Scenario Estimated Percentage
IPOScenarioEstimatedPercentage
0.75 pure
CY2021 asns Ipo Scenario Estimated Percentage
IPOScenarioEstimatedPercentage
0.375 pure
CY2022Q1 us-gaap Additional Liability Long Duration Insurance Current Weighted Average Discount Rate
AdditionalLiabilityLongDurationInsuranceCurrentWeightedAverageDiscountRate
0.40 pure
CY2022Q1 us-gaap Debt Conversion Converted Instrument Rate
DebtConversionConvertedInstrumentRate
0.772 pure
CY2021 us-gaap Debt Conversion Converted Instrument Rate
DebtConversionConvertedInstrumentRate
0.772 pure
CY2022Q1 us-gaap Financial Guarantee Insurance Contracts Claim Liability Weighted Average Risk Free Discount Rate
FinancialGuaranteeInsuranceContractsClaimLiabilityWeightedAverageRiskFreeDiscountRate
0.214 pure
CY2021 us-gaap Financial Guarantee Insurance Contracts Claim Liability Weighted Average Risk Free Discount Rate
FinancialGuaranteeInsuranceContractsClaimLiabilityWeightedAverageRiskFreeDiscountRate
0.208 pure
CY2022Q1 asns Share Based Goods And Nonemployee Services Transaction Valuations Method Expected Dividend Rate
ShareBasedGoodsAndNonemployeeServicesTransactionValuationsMethodExpectedDividendRate
0.25 pure
CY2021 asns Share Based Goods And Nonemployee Services Transaction Valuations Method Expected Dividend Rate
ShareBasedGoodsAndNonemployeeServicesTransactionValuationsMethodExpectedDividendRate
0.625 pure
CY2022Q1 asns Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm
P2Y9M
CY2021 asns Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm
P3Y
CY2022Q1 us-gaap Equity Fair Value Adjustment
EquityFairValueAdjustment
26500000 usd
CY2021 us-gaap Equity Fair Value Adjustment
EquityFairValueAdjustment
24300000 usd
CY2022Q1 asns Volatility Percentages
VolatilityPercentages
0.58 pure
CY2021 asns Volatility Percentages
VolatilityPercentages
0.58 pure
CY2022Q1 asns Riskfree Rate Percentage
RiskfreeRatePercentage
0.0241 pure
CY2021 asns Riskfree Rate Percentage
RiskfreeRatePercentage
0.0097 pure
CY2022Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
4905000 usd
CY2021Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
3563000 usd
us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
1648000 usd
CY2021 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
1342000 usd
asns Conversion Of Stock Amount Issued
ConversionOfStockAmountIssued
6553000 usd
CY2021 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
4905000 usd
CY2021Q4 us-gaap Loans And Leases Receivable Before Fees Gross
LoansAndLeasesReceivableBeforeFeesGross
516000 usd
us-gaap Credit Derivative Liquidation Proceeds Percentage
CreditDerivativeLiquidationProceedsPercentage
1 pure
CY2022Q3 us-gaap Billed Contract Receivables
BilledContractReceivables
14300000 usd
CY2022Q3 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
15500000 usd
CY2022Q3 us-gaap Recorded Unconditional Purchase Obligation Amount Of Maturities And Sinking Fund Requirements
RecordedUnconditionalPurchaseObligationAmountOfMaturitiesAndSinkingFundRequirements
10000000 usd
CY2022Q3 us-gaap Servicing Liability
ServicingLiability
1006000 usd
CY2021Q4 us-gaap Servicing Liability
ServicingLiability
818000 usd
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
890493 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.15
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y5M4D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
75001 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.34
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
15460 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.07
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
9851 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.66
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
940183 shares
CY2021Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
usd
CY2022Q3 us-gaap Costs And Expenses
CostsAndExpenses
0 usd
CY2022Q3 us-gaap Noncurrent Assets
NoncurrentAssets
108000 usd
CY2021Q4 us-gaap Noncurrent Assets
NoncurrentAssets
103000 usd
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.45
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P5Y18D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
820157 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.11
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y6M
us-gaap Option Indexed To Issuers Equity Shares
OptionIndexedToIssuersEquityShares
940183 shares
us-gaap Option Indexed To Issuers Equity Shares
OptionIndexedToIssuersEquityShares
891218 shares
us-gaap Stock Option Exercise Price Increase
StockOptionExercisePriceIncrease
0.453
us-gaap Stock Option Exercise Price Increase
StockOptionExercisePriceIncrease
0.15
us-gaap Common Stock Dividends Shares
CommonStockDividendsShares
7731083 shares
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 pure
CY2022Q3 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
1348000 usd
CY2021Q3 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
1422000 usd
us-gaap Revenue From Related Parties
RevenueFromRelatedParties
6297000 usd
us-gaap Revenue From Related Parties
RevenueFromRelatedParties
5995000 usd
CY2022Q3 asns Contract With Customer Liability Revenue Recognize
ContractWithCustomerLiabilityRevenueRecognize
673000 usd
CY2021Q4 asns Contract With Customer Liability Revenue Recognize
ContractWithCustomerLiabilityRevenueRecognize
581000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-513000 usd
CY2021 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-452000 usd
CY2022Q3 asns Additions
Additions
658000 usd
CY2021Q4 asns Additions
Additions
544000 usd
CY2022Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
818000 usd
CY2021Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
673000 usd
CY2022Q3 us-gaap Purchase Obligation
PurchaseObligation
818 usd
asns Revenues Percentage
RevenuesPercentage
0.10 pure
us-gaap Costs And Expenses
CostsAndExpenses
0 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
usd
CY2021Q3 us-gaap Costs And Expenses
CostsAndExpenses
1648000 usd
us-gaap Costs And Expenses
CostsAndExpenses
0 usd
CY2016Q3 us-gaap Stock Issued During Period Shares Purchase Of Assets
StockIssuedDuringPeriodSharesPurchaseOfAssets
73048 shares
CY2021 asns Ipo Scenario Estimated Percentage
IPOScenarioEstimatedPercentage
0.375 pure
CY2021 asns Private Holding Percenatge
PrivateHoldingPercenatge
0.625 pure
CY2021 asns Volatility Percentage
VolatilityPercentage
0.58 pure
CY2021 asns Riskfree Rate Percentage
RiskfreeRatePercentage
0.0097 pure
CY2021 us-gaap Debt Instrument Term
DebtInstrumentTerm
P0Y4M24D
CY2021 asns Ipo Scenario Expected Term
IPOScenarioExpectedTerm
P3Y
CY2022Q3 asns Underlying Common Stock Price
UnderlyingCommonStockPrice
0.875
asns Volatility Percentage
VolatilityPercentage
0.57 pure
asns Risk Free Rate Percentage
RiskFreeRatePercentage
0.0416 pure
us-gaap Debt Instrument Term
DebtInstrumentTerm
P3Y10M24D
CY2021Q4 us-gaap Servicing Asset At Fair Value Amount
ServicingAssetAtFairValueAmount
2149000 usd
CY2020Q4 us-gaap Servicing Asset At Fair Value Amount
ServicingAssetAtFairValueAmount
1023000 usd
us-gaap Servicing Liability At Fair Value Other Changes In Fair Value
ServicingLiabilityAtFairValueOtherChangesInFairValue
1068000 usd
CY2021 us-gaap Servicing Liability At Fair Value Other Changes In Fair Value
ServicingLiabilityAtFairValueOtherChangesInFairValue
1031000 usd
CY2021 us-gaap Servicing Asset At Fair Value Additions
ServicingAssetAtFairValueAdditions
95000 usd
CY2022Q3 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
3190000 usd
CY2022Q3 us-gaap Servicing Asset At Fair Value Amount
ServicingAssetAtFairValueAmount
27000 usd
CY2021Q4 us-gaap Servicing Asset At Fair Value Amount
ServicingAssetAtFairValueAmount
2149000 usd
CY2022Q3 us-gaap Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
-47000 usd
us-gaap Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
1068000 usd
CY2021Q3 us-gaap Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
0 usd
us-gaap Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
0 usd
CY2022Q3 us-gaap Lease Income
LeaseIncome
40000 usd
us-gaap Lease Income
LeaseIncome
121000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
818000 usd
CY2022Q3 asns Current Operating Lease Liabilities
CurrentOperatingLeaseLiabilities
480000 usd
CY2022Q3 asns Non Current Operating Lease Liabilities
NonCurrentOperatingLeaseLiabilities
276000 usd
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
756000 usd
CY2021Q4 us-gaap Notes Payable Related Parties Current And Noncurrent
NotesPayableRelatedPartiesCurrentAndNoncurrent
usd
CY2022Q3 us-gaap Notes Payable Related Parties Current And Noncurrent
NotesPayableRelatedPartiesCurrentAndNoncurrent
usd
CY2021 asns Conversion Of Stock Amount Issued
ConversionOfStockAmountIssued
usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
usd
us-gaap Servicing Asset At Fair Value Additions
ServicingAssetAtFairValueAdditions
usd
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
usd
CY2015Q1 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
106000 usd
CY2022Q2 us-gaap Defined Benefit Plan Number Of Shares Of Equity Securities Issued By Employer And Related Parties Included In Plan Assets
DefinedBenefitPlanNumberOfSharesOfEquitySecuritiesIssuedByEmployerAndRelatedPartiesIncludedInPlanAssets
27699 shares
CY2022Q2 asns Related Party Transactions Purchases From Related Party
RelatedPartyTransactionsPurchasesFromRelatedParty
4.55
CY2022Q2 us-gaap Equity Method Investment Aggregate Cost
EquityMethodInvestmentAggregateCost
126000 usd
CY2015Q1 asns Related Party Fair Value Price Per Share
RelatedPartyFairValuePricePerShare
0.55
CY2015Q1 us-gaap Management Fee Expense
ManagementFeeExpense
5000 usd
us-gaap Related Party Tax Expense Due To Affiliates Current
RelatedPartyTaxExpenseDueToAffiliatesCurrent
150000 usd
us-gaap Related Party Transaction Other Revenues From Transactions With Related Party
RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty
4000000 usd
CY2022Q1 us-gaap Warrant Down Round Feature Decrease In Net Income Loss To Common Shareholder Amount
WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount
100000 usd
CY2022Q2 us-gaap Other Additional Capital
OtherAdditionalCapital
50000 usd
CY2022Q1 asns Aggregate Amount
aggregateAmount
100000 usd
CY2022Q1 us-gaap Collateralized Agreements
CollateralizedAgreements
150000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
usd
CY2021Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
usd
CY2022Q3 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
usd
CY2022Q3 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
usd
CY2022Q3 us-gaap Redeemable Noncontrolling Interest Equity Preferred Carrying Amount
RedeemableNoncontrollingInterestEquityPreferredCarryingAmount
usd
CY2022Q3 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
usd
CY2021Q4 asns Common Stock Value1
CommonStockValue1
usd
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.93
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9687205 shares
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
usd
CY2022Q2 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
usd
asns Changes In Fair Value Related To Convertible Loan
ChangesInFairValueRelatedToConvertibleLoan
usd
us-gaap Operating Lease Payments
OperatingLeasePayments
520000 usd
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y6M18D
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0311 pure
us-gaap Operating Lease Cost
OperatingLeaseCost
504000 usd
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
168000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
16000 usd
CY2022Q3 us-gaap Variable Lease Cost
VariableLeaseCost
8000 usd
us-gaap Lease Cost
LeaseCost
520000 usd
CY2022Q3 us-gaap Lease Cost
LeaseCost
178000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
150000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
444000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
153000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
61000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
808000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
52000 usd
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
756000 usd
asns Changes In Fair Value Related To Convertible Note
ChangesInFairValueRelatedToConvertibleNote
usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
usd
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
usd
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
usd
us-gaap Payments For Repurchase Of Initial Public Offering
PaymentsForRepurchaseOfInitialPublicOffering
usd
CY2021Q4 us-gaap Loans And Leases Receivable Before Fees Gross
LoansAndLeasesReceivableBeforeFeesGross
516000 usd
us-gaap Credit Derivative Liquidation Proceeds Percentage
CreditDerivativeLiquidationProceedsPercentage
1 pure
CY2022Q3 us-gaap Billed Contract Receivables
BilledContractReceivables
14300000 usd
CY2022Q3 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
15500000 usd
CY2022Q3 us-gaap Recorded Unconditional Purchase Obligation Amount Of Maturities And Sinking Fund Requirements
RecordedUnconditionalPurchaseObligationAmountOfMaturitiesAndSinkingFundRequirements
10000000 usd
CY2022Q3 us-gaap Servicing Liability
ServicingLiability
1006000 usd
CY2021Q4 us-gaap Servicing Liability
ServicingLiability
818000 usd
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
890493 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.15
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y5M4D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
75001 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.34
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
15460 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.07
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
9851 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.66
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
940183 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.45
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P5Y18D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
820157 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.11
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y6M
CY2021Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
asns Revenues Percentage
RevenuesPercentage
0.10 pure
us-gaap Option Indexed To Issuers Equity Shares
OptionIndexedToIssuersEquityShares
940183 shares
us-gaap Option Indexed To Issuers Equity Shares
OptionIndexedToIssuersEquityShares
891218 shares
us-gaap Stock Option Exercise Price Increase
StockOptionExercisePriceIncrease
0.453
us-gaap Stock Option Exercise Price Increase
StockOptionExercisePriceIncrease
0.15
us-gaap Common Stock Dividends Shares
CommonStockDividendsShares
7731083 shares
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 pure
CY2022Q3 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
1348000 usd
CY2021Q3 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
1422000 usd
us-gaap Revenue From Related Parties
RevenueFromRelatedParties
6297000 usd
us-gaap Revenue From Related Parties
RevenueFromRelatedParties
5995000 usd
CY2022Q3 asns Contract With Customer Liability Revenue Recognize
ContractWithCustomerLiabilityRevenueRecognize
673000 usd
CY2021Q4 asns Contract With Customer Liability Revenue Recognize
ContractWithCustomerLiabilityRevenueRecognize
581000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-513000 usd
CY2021 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-452000 usd
CY2022Q3 asns Additions
Additions
658000 usd
CY2021Q4 asns Additions
Additions
544000 usd
CY2022Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
818000 usd
CY2021Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
673000 usd
CY2022Q3 us-gaap Purchase Obligation
PurchaseObligation
818 usd
CY2022Q3 us-gaap Noncurrent Assets
NoncurrentAssets
108000 usd
CY2021Q4 us-gaap Noncurrent Assets
NoncurrentAssets
103000 usd
dei Entity Central Index Key
EntityCentralIndexKey
0001141284
CY2015Q1 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
106000 usd
CY2022Q2 us-gaap Defined Benefit Plan Number Of Shares Of Equity Securities Issued By Employer And Related Parties Included In Plan Assets
DefinedBenefitPlanNumberOfSharesOfEquitySecuritiesIssuedByEmployerAndRelatedPartiesIncludedInPlanAssets
27699 shares
CY2022Q2 asns Related Party Transactions Purchases From Related Party
RelatedPartyTransactionsPurchasesFromRelatedParty
4.55
CY2022Q2 us-gaap Equity Method Investment Aggregate Cost
EquityMethodInvestmentAggregateCost
126000 usd
CY2015Q1 asns Related Party Fair Value Price Per Share
RelatedPartyFairValuePricePerShare
0.55
CY2015Q1 us-gaap Management Fee Expense
ManagementFeeExpense
5000 usd
us-gaap Related Party Tax Expense Due To Affiliates Current
RelatedPartyTaxExpenseDueToAffiliatesCurrent
150000 usd
us-gaap Related Party Transaction Other Revenues From Transactions With Related Party
RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty
4000000 usd
CY2022Q1 us-gaap Warrant Down Round Feature Decrease In Net Income Loss To Common Shareholder Amount
WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount
100000 usd
CY2022Q2 us-gaap Other Additional Capital
OtherAdditionalCapital
50000 usd
CY2022Q1 asns Aggregate Amount
aggregateAmount
100000 usd
CY2022Q1 us-gaap Collateralized Agreements
CollateralizedAgreements
150000 usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001141284

Files In Submission

Name View Source Status
0001213900-22-071537-index-headers.html Edgar Link pending
0001213900-22-071537-index.html Edgar Link pending
0001213900-22-071537.txt Edgar Link pending
0001213900-22-071537-xbrl.zip Edgar Link pending
asns-20220930.xsd Edgar Link pending
f10q0922ex31-1_actelisnet.htm Edgar Link pending
f10q0922ex31-2_actelisnet.htm Edgar Link pending
f10q0922ex32-1_actelisnet.htm Edgar Link pending
f10q0922ex32-2_actelisnet.htm Edgar Link pending
f10q0922_actelisnet.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
asns-20220930_cal.xml Edgar Link unprocessable
asns-20220930_def.xml Edgar Link unprocessable
asns-20220930_lab.xml Edgar Link unprocessable
asns-20220930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
f10q0922_actelisnet_htm.xml Edgar Link completed
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending